SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

A quarterly revenue miss and large non-cash impairment tied to decommissioning bitcoin-mining equipment triggered a sharp selloff, with traders also concerned about heavy future capex, dilution risk, and unclear guidance. Bulls argue the charge reflects IRENs transition to AI cloud infrastructure and point to rising AI revenue, contracted capacity, and the Microsoft ramp, while bears question execution, valuation, and management credibility.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

Reports that Advent International and Stripe abandoned their potential PayPal takeover have erased the acquisition premium and shifted attention back to the companys standalone fundamentals. Traders are divided between bears citing competitive and growth concerns and bulls arguing the offer undervalued PayPal, with cash generation, buybacks and potential renewed interest supporting the long-term case.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

A post-earnings selloff is driving attention after Marvell delivered a modest beat and raised its multi-year outlook, but traders focused on lower near-term gross margins and the view that the Google AI-chip deals major revenue contribution arrives later than expected. Bulls see the decline as an overreaction to strong AI infrastructure demand and analyst upgrades, while bears argue the valuation and elevated expectations left little room for disappointment.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Federal Reserve Chair Kevin Warshs Jackson Hole speech, which emphasized persistent inflation and a less predictable, data-dependent policy approach, has centered debate on the possibility of a September rate hike. Despite the hawkish interpretation, SPY rallied, leading traders to argue that markets are shrugging off rate risks while others view the move as a fragile, positioning-driven rally vulnerable to a pullback.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Post-earnings selling, tied to a slight revenue miss and below-consensus guidance, has kept AppLovin in focus alongside a wave of analyst price-target cuts. Bulls view the decline as an overreaction and point to e-commerce ad expansion, strong fundamentals, buybacks and possible short covering, while bears remain concerned about slowing growth, execution and the stocks persistent downtrend.

Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce. Its platform consists of three core elements: a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The company was founded by Max R. Levchin in 2012 and is headquartered in San Francisco, CA.

Affirm Holdings Inc - Ordinary Shares - Class A

Affirm Holdings Inc

A better-than-expected quarterly report and upbeat forward outlook are driving attention, with traders highlighting strong growth, profitability, and continued merchant adoption. The community is split between bullish views that the results validate Affirms growth story and concerns that a one-time profit boost, elevated valuation, credit risk, and the stocks recurring post-earnings selloff could limit the move.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

A blowout quarterly report and stronger forward outlook have renewed enthusiasm around NVIDIAs AI-chip demand and the broader AI infrastructure trade. Traders remain divided as the stock pulls back after the earnings surge, with profit-taking, options positioning, valuation and balance-sheet concerns competing with bullish views that demand remains robust; Federal Reserve rate uncertainty is adding volatility.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitass quarterly report is driving attention: revenue beat expectations and management projected continued growth in high-power AI infrastructure, but a wider loss, ongoing dilution concerns, and the lack of confirmed hyperscaler contracts have triggered a sharp debate between long-term AI-power bulls and more cautious traders.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

An expanded AWSNVIDIA partnership, including plans to deploy additional GPUs for AI infrastructure, agentic AI and warehouse robotics, is driving attention and a sharp bullish reaction. Traders view the deal as confirmation of AWSs AI and cloud growth potential, while others remain cautious about the capital intensity, rising depreciation and pressure on free cash flow.

LightPath Technologies, Inc. engages in the design, development, manufacture, and distribution of optical and infrared components. Its products include molded glass and assemblies, infrared molded lenses, diamond turned, conventional ground and polished ground lenses and assemblies, and collimator assemblies, which are used in applications involving light detection and ranging technology. The firm supports a range of customers in the field of industrial, laser, defense, medical, telecommunications, and instrumentation. The company was founded in1985 and is headquartered in Orlando, FL.

Lightpath Technologies, Inc. - Ordinary Shares - Class A

The selloff is centered on the Armys notice seeking additional potential sources for the NGSRI Stinger replacement program, which traders fear could increase competition or delay the down-selection tied to LightPaths Lockheed-related opportunity. Other traders argue the notice does not change the targeted production timeline or eliminate LightPaths seeker exposure, calling the reaction an overinterpretation amid broader weakness in drone and defense stocks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SRPT On Track For Best Week In 5 Months Ahead Of Late-2026 Clinical Data — Retail Eyes ‘Monumental Comeback’

Anticipation of Sareptas FSHD and DM1 clinical readouts, alongside a setback for rival Capricors DMD therapy, is supporting a rebound in SRPT. Traders are debating whether the sharp move reflects short covering and heavy options activity or unconfirmed buyout and news-leak speculation.

The move appears tied to renewed anticipation of Sareptas upcoming facioscapulohumeral and myotonic dystrophy clinical data, alongside rival Capricors delayed Deramiocel FDA decision, which could reduce near-term competition in Duchenne muscular dystrophy. Elevated volume and heavy short interest may have amplified the reaction, while buyout and news-leak claims remain unconfirmed.

Equity

Investors are now awaiting extra data from Sarepta’s mid-stage studies in two muscle diseases, facioscapulohumeral muscular dystrophy and myotonic dystrophy.


KROS $20M Takeda Milestone Adds Cash but Revenue Visibility Stays Weak

Keros gets a $20M Takeda milestone, boosting cash and flexibility, but weak revenue visibility keeps collaboration income in focus.

Should You Buy KROS Stock as Pipeline Promise Meets Revenue Risk?

Keros' rinvatercept pipeline offers upside, but zero quarterly revenue, clinical risk and a premium valuation make the stock a cautious bet.

Sarepta Therapeutics Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sarepta Therapeutics, Inc. - SRPT

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (KSF), announces that KSF has commenced an investigation into Sarepta Therapeutics, Inc. (NasdaqGS: SRPT) (Sarepta or the Company).Sarepta is a biopharmaceutical company focused on...

Sarepta's Q2 Earnings & Sales Beat Estimates, '26 Outlook Updated

SRPT beat Q2 earnings and revenue estimates despite weaker Elevidys sales, while narrowing its 2026 product revenue outlook and tightening expense guidance.

Sarepta Therapeutics (SRPT) Q2 Earnings and Revenues Surpass Estimates

Sarepta Therapeutics (SRPT) delivered earnings and revenue surprises of +10.35% and +12.85%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Compared to Estimates, Sarepta Therapeutics (SRPT) Q2 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Sarepta Therapeutics (SRPT) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Sarepta Therapeutics Announces Second Quarter 2026 Financial Results and Recent Corporate Developments

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for the second quarter of 2026. As I begin my tenure as CEO, I am excited by the strength of Sarepta's foundation, the impact our therapies are having for patients...

ANI Pharmaceuticals (ANIP) Reports Next Week: Wall Street Expects Earnings Growth

ANI (ANIP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on July 28, 2026, that were previously approved by its Board of Directors under Sareptas 2024 Employment Commencement Incentive Plan, as amended, as a material inducement to...

• Reported GAAP EPS of -$0.05 down -102.49% YoY
• Reported revenue of $401.25M down -34.34% YoY
• Sarepta Therapeutics narrowed its 2026 total net product revenue guidance to $1.2-$1.3 billion and narrowed combined non-GAAP R&D and SG&A expense guidance to $800.0-$850.0 million for the full year.

Sarepta Therapeutics experienced a 34% revenue decline due to lower ELEVIDYS sales, incurred a $39 million litigation charge, and faces ongoing regulatory and commercial adoption risks for its product portfolio.

Sarepta Therapeutics achieved quarterly operating profitability, appointed a new CEO with extensive industry experience, and strengthened its financial position with a $197 million increase in cash and investment holdings.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Extremely Bullish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a positive week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Stocktwits

Stocktwits Polls

Investors are speculating on potential acquisition interest from big pharma as technical volume builds.

Significant capital has been spotted flowing into long-term call spreads, hinting at major catalysts approaching.

Traders are closely monitoring heavy short interest, hoping for a volatility spike to force positions to cover.

Market attention is pivoting toward upcoming clinical data readouts that could redefine the company's long-term valuation.

Current Price	$21.59
Prev Close	$21.59
Open	$21.48
Dividend Yield	0.00%
50-Day Moving Average	$17.61
Beta	1.24
Avg. Volume	3.16M
PE Ratio	-7.45

52-Week High	$25.32
52-Week Low	$14.68
Market Capitalization	$2.28B
EPS (Annual)	-$7.13
Price to Book	1.49
Revenue Per Employee	$2.63M

Feed

News

Sentiment

Earnings

Fundamentals

Info